(Q35796413)

English

Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization

scientific article published on December 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

author name string

Zheng MH

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Fan Y

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Panicker A

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Smith A

4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Robertson T

5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Wysocki S

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Robbins P

7

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Papadimitriou JM

8

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Wood DJ

9

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

language of work or name

0 references

publication date

1 December 1995

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

The American Journal of Pathology

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

147

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1559-1566

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Giant-cell tumor of bone: analysis of two hundred and eight cases in Chinese patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Human giant cell tumors of bone identification and characterization of cell types

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Plasminogen activators, tissue degradation, and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Growth stimulation of human epidermal cells by urokinase is restricted to the intact active enzyme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Plasminogen activator inhibitors: hormonally regulated serpins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Directed plasminogen activation at the surface of normal and malignant cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Components of the Plasminogen-Plasmin System in Human Tumor Cell Lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Production of matrix metalloproteinases 2 and 3 (stromelysin) by stromal cells of giant cell tumor of bone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

The plasminogen-plasmin system in malignancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Giant-cell tumor of bone. A demographic, clinical, and histopathological study of all cases recorded in the Swedish Cancer Registry for the years 1958 through 1968

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Giant cell tumor of bone: detailed fine structural analysis of different cell components

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

11 July 2018

Growth rate analysis of lung metastases from histologically benign giant cell tumor of bone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

25 September 2018

Giant-cell tumor of bone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1869931

25 September 2018

Biologic characterization of human bone tumors. III. Giant cell tumor of bone. A combined electron microscopical, histochemical, and autoradiographical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7495280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of Ia and monocyte-macrophage lineage antigens in giant cell tumor of bone and related lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/7495280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carbonic anhydrase II gene transcript in cultured osteoclasts from neonatal rats: effect of calcitonin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7495280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Giant cell tumor bone. Enzyme histochemical, biochemical and tissue culture studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/7495280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of mRNA for carbonic anhydrase II in human osteoclast-like cells by in situ hybridization

1 reference

https://pubmed.ncbi.nlm.nih.gov/7495280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Giant-cell tumour of bone: an analysis of fifty-two cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/7495280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastases from histologically benign giant-cell tumor of bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/7495280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benign and malignant giant cell tumors of bone.A clinicopathological analysis of the natural history of the disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/7495280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Giant cell tumor of bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/7495280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin

1 reference

https://pubmed.ncbi.nlm.nih.gov/7495280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benign metastasizing giant cell tumors of bone. A DNA flow cytometric study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7495280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ultrastructure of giant cell tumors of bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/7495280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Giant-cell tumor of bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/7495280

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35796413&oldid=1697162618"